Harvey Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-61,626
Closed -$6.12M 81
2019
Q3
$6.12M Sell
61,626
-300
-0.5% -$28.5K 3.04% 8
2019
Q2
$5.72M Sell
61,926
-301
-0.5% -$28.6K 2.75% 11
2019
Q1
$5.87M Sell
62,227
-19,120
-24% -$1.67M 2.82% 11
2018
Q4
$5.21M Buy
81,347
+7,067
+10% +$522K 2.77% 11
2018
Q3
$6.65M Buy
74,280
+400
+0.5% +$35.3K 2.65% 12
2018
Q2
$5.87M Sell
73,880
-400
-0.5% -$33.2K 2.33% 15
2018
Q1
$6.63M Buy
74,280
+1,025
+1% +$98.4K 2.48% 13
2017
Q4
$7.64M Buy
73,255
+7,955
+12% +$898K 2.77% 10
2017
Q3
$9.52M Sell
65,300
-125
-0.2% -$17K 3.84% 4
2017
Q2
$8.5M Buy
65,425
+425
+0.7% +$52.1K 3.64% 6
2017
Q1
$8.09M Buy
65,000
+620
+1% +$74.2K 3.63% 7
2016
Q4
$7.45M Sell
64,380
-725
-1% -$80.7K 3.47% 7
2016
Q3
$6.8M Buy
65,105
+805
+1% +$87.1K 2.1% 12
2016
Q2
$6.34M Sell
64,300
-12,250
-16% -$1.27M 3.18% 11
2016
Q1
$7.66M Sell
76,550
-2,400
-3% -$247K 3.71% 9
2015
Q4
$9.46M Sell
78,950
-31,975
-29% -$3.7M 3.73% 6
2015
Q3
$12M Sell
110,925
-26,225
-19% -$3.25M 4.79% 5
2015
Q2
$16.4M Sell
137,150
-9,850
-7% -$1.13M 5.55% 3
2015
Q1
$16.9M Sell
147,000
-3,100
-2% -$370K 6.23% 2
2014
Q4
$16.8M Sell
150,100
-4,400
-3% -$464K 6.44% 3
2014
Q3
$14.6M Sell
154,500
-500
-0.3% -$45.1K 5.74% 3
2014
Q2
$13.3M Buy
155,000
+29,100
+23% +$2.21M 4.76% 5
2014
Q1
$8.79M Sell
125,900
-10,000
-7% -$792K 3.5% 10
2013
Q4
$11.5M Sell
135,900
-2,000
-1% -$158K 4.74% 7
2013
Q3
$10.6M Sell
137,900
-24,900
-15% -$1.74M 5.4% 4
2013
Q2
$9.52M Buy
+162,800
New +$9.8M 5.91% 1

Other funds holding CELG

Harvey Capital Management's CELG Position: Q4 2019 in Review

Harvey Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 61,626 shares — an estimated $6.12M sold.

Harvey Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $16.9M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Harvey Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Harvey Capital Management sold 61,626 Celgene Corp shares in Q4 2019, an estimated $6.12M.
  • Harvey Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Harvey Capital Management's Celgene Corp position peaked at $16.9M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Harvey Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.